Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 14, Issue 1, Pages 15-22
Publisher
Informa UK Limited
Online
2016-11-01
DOI
10.1080/17425247.2016.1256283
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- THU0198 Patient Evaluations of Autoinjectors for Delivery of Subcutaneous Golimumab for Treatment of Rheumatoid Arthritis
- (2014) H. Schulze-Koops et al. ANNALS OF THE RHEUMATIC DISEASES
- THU0464-HPR Nursing evaluation in the etanercept switching from a prefilled syringe into a pen myclic in patients with chronic arthritis
- (2014) S. Garcia-Diaz et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of injection speed and volume on perceived pain during subcutaneous injections into the abdomen and thigh: a single-centre, randomized controlled trial
- (2014) T. Heise et al. DIABETES OBESITY & METABOLISM
- Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals
- (2014) Andreas Pfützner et al. Expert Opinion on Drug Delivery
- New autoinjector technology for the delivery of subcutaneous methotrexate in the treatment of rheumatoid arthritis
- (2014) Michael Schiff et al. Expert Review of Medical Devices
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen
- (2013) Joaquín Borrás-Blasco et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or Etanercept
- (2012) N. Tandon et al. VALUE IN HEALTH
- Comparison of patient satisfaction with two different etanercept delivery systems
- (2012) U. Müller-Ladner et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- The effect of a new syringe design on the ability of rheumatoid arthritis patients to inject a biological medication
- (2011) Ali Sheikhzadeh et al. APPLIED ERGONOMICS
- Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning
- (2011) Daniel A. Nadeau et al. CURRENT MEDICAL RESEARCH AND OPINION
- Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals
- (2011) T. Bailey et al. CURRENT MEDICAL RESEARCH AND OPINION
- Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ)
- (2011) Dorothy Keininger et al. Health and Quality of Life Outcomes
- Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen
- (2010) Joaquín Borrás-Blasco et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- A Comparison of Insulin Injection Needles on Patients' Perceptions of Pain, Handling, and Acceptability: A Randomized, Open-Label, Crossover Study in Subjects with Diabetes
- (2009) Maureen McKay et al. Diabetes Technology & Therapeutics
- The Rheumatoid Thumb
- (2008) Aron T. Chacko et al. HAND CLINICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started